Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT03136458

Efficacy of Remote Ischemic Preconditioning as Non Pharmacologic Strategy to Prevent Contrast Induced Nephropathy (PAIR)

Efficacy of Remote Ischemic Preconditioning as Non Pharmacologic Strategy to Prevent Contrast Induced Nephropathy (PAIR Trial)

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Camilo Andrés Páez Angarita · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study evaluates remote ischemic preconditioning as an strategy to avoid contrast induced nephropathy. All of the patients will receive endovenous normal saline to prevent nephropathy, half of the patients will receive remote ischemic preconditioning while the other half will not.

Detailed description

This study evaluates remote ischemic preconditioning as an strategy to avoid contrast induced nephropathy, this preconditioning is administered through repeated insufflation of an arterial pressure cuff in one of the patient arms, which in theory liberates vasoactive mediators that prevents the ischemic damage to the kidneys secondary to contrast media. All of the patients will receive endovenous normal saline to prevent nephropathy, which is a common strategy in our institution. Half of the patients will receive remote ischemic preconditioning while the other half will only receive a dummy preconditioning intended to keep the double blind strategy of the trial. The main endpoint will be to ascertain the incidence of contrast induced nephropathy in both arms of the study, as a way to evaluate the efficacy of this strategy.

Conditions

Interventions

TypeNameDescription
PROCEDUREIschemic preconditioningRepeated remote ischemic preconditioning by arterial cuff insufflation.
DRUGEndovenous normal salineendovenous normal saline 1 mL per Kg per hour before and after contrast media injection.

Timeline

Start date
2016-01-01
Primary completion
2018-10-09
Completion
2018-10-09
First posted
2017-05-02
Last updated
2018-10-11

Locations

1 site across 1 country: Colombia

Source: ClinicalTrials.gov record NCT03136458. Inclusion in this directory is not an endorsement.